SE7701441L - Nytt piperazinyluracilsalt - Google Patents

Nytt piperazinyluracilsalt

Info

Publication number
SE7701441L
SE7701441L SE7701441A SE7701441A SE7701441L SE 7701441 L SE7701441 L SE 7701441L SE 7701441 A SE7701441 A SE 7701441A SE 7701441 A SE7701441 A SE 7701441A SE 7701441 L SE7701441 L SE 7701441L
Authority
SE
Sweden
Prior art keywords
urapidil
furosemide
combination
salt
piperazinyluracil
Prior art date
Application number
SE7701441A
Other languages
English (en)
Swedish (sv)
Inventor
H Amschler
K Klemm
G Ludwig
W Schoetensack
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of SE7701441L publication Critical patent/SE7701441L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7701441A 1976-02-09 1977-02-09 Nytt piperazinyluracilsalt SE7701441L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU74319A LU74319A1 (en, 2012) 1976-02-09 1976-02-09

Publications (1)

Publication Number Publication Date
SE7701441L true SE7701441L (sv) 1977-08-10

Family

ID=19728151

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7701441A SE7701441L (sv) 1976-02-09 1977-02-09 Nytt piperazinyluracilsalt

Country Status (20)

Country Link
US (1) US4131678A (en, 2012)
JP (2) JPS5296718A (en, 2012)
AT (1) AT347478B (en, 2012)
BE (1) BE851267A (en, 2012)
CA (1) CA1065865A (en, 2012)
CH (1) CH625792A5 (en, 2012)
DE (1) DE2704935C2 (en, 2012)
DK (1) DK52877A (en, 2012)
ES (1) ES455721A1 (en, 2012)
FI (1) FI61891C (en, 2012)
FR (1) FR2340316A1 (en, 2012)
GB (1) GB1512771A (en, 2012)
IE (1) IE44461B1 (en, 2012)
IL (1) IL51400A (en, 2012)
IT (1) IT1075919B (en, 2012)
LU (1) LU74319A1 (en, 2012)
NL (1) NL7701289A (en, 2012)
NO (1) NO145440C (en, 2012)
SE (1) SE7701441L (en, 2012)
YU (1) YU32477A (en, 2012)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58130183U (ja) * 1982-02-26 1983-09-02 株式会社ブレスト工業研究所 空調ダクト等の吊持装置
US4663348A (en) * 1985-07-02 1987-05-05 Warner-Lambert Co. Furosemide salts and pharmaceutical preparations thereof
IE62890B1 (en) * 1988-12-06 1995-03-08 Hafslund Nycomed Pharma New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure
DE3902316A1 (de) * 1989-01-26 1990-08-02 Lentia Gmbh Neue piperazinylalkyl-3(2h)-pyridazinone, verfahren zu ihrer herstellung und ihre verwendung als blutdrucksenkende mittel
JP2815218B2 (ja) * 1990-04-13 1998-10-27 三井化学株式会社 ピリミジンジオン誘導体、およびそれを含有する抗不整脈剤
CN100353944C (zh) * 2004-06-24 2007-12-12 杨立新 乌拉地尔大容量注射液、其制备方法及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
BE755015A (fr) * 1969-08-20 1971-02-01 Byk Gulden Lomberg Chem Fab Piperazinyl-alcoylamino-uraciles substitues par un groupe aryle, leurs ethers et thioethers, ainsi que leur procede de preparation
JPS5212560A (en) * 1975-07-21 1977-01-31 Hitachi Ltd Electronic beam probe control device

Also Published As

Publication number Publication date
ATA81777A (de) 1978-05-15
NO145440B (no) 1981-12-14
FI770406A7 (en, 2012) 1977-08-10
IL51400A (en) 1980-12-31
BE851267A (fr) 1977-08-09
DE2704935C2 (de) 1985-01-10
FR2340316B1 (en, 2012) 1980-02-08
NO145440C (no) 1982-03-24
YU32477A (en) 1982-06-30
GB1512771A (en) 1978-06-01
AT347478B (de) 1978-12-27
JPS5713544B2 (en, 2012) 1982-03-17
ES455721A1 (es) 1978-01-01
JPS5726618A (en) 1982-02-12
DE2704935A1 (de) 1977-08-11
IE44461L (en) 1977-08-09
NL7701289A (nl) 1977-08-11
FI61891B (fi) 1982-06-30
FR2340316A1 (fr) 1977-09-02
IL51400A0 (en) 1977-04-29
JPS5296718A (en) 1977-08-13
CA1065865A (en) 1979-11-06
NO770411L (no) 1977-08-10
IT1075919B (it) 1985-04-22
LU74319A1 (en, 2012) 1977-08-19
FI61891C (fi) 1982-10-11
IE44461B1 (en) 1981-12-02
DK52877A (da) 1977-08-10
US4131678A (en) 1978-12-26
CH625792A5 (en, 2012) 1981-10-15

Similar Documents

Publication Publication Date Title
ES2096673T3 (es) Uso de sulfonamidas como medicamentos y nuevas sulfonamidas.
ES2071484T3 (es) Derivados de 2,4-diaminoquinazolinas para aumentar la actividad antitumoral.
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
ES2106794T3 (es) Utilizacion del inositol-trifosfato para el tratamiento de inflamaciones.
SE437837B (sv) Polypeptid for att kontrollera och/eller forbettra reproduktionen hos djur jemte veteriner komposition innehallande nemnda polypeptid som aktiv bestandsdel
NO821832L (no) Fremgangsmaate for fremstilling av allergenholdige kapsler
DK0574457T3 (da) Antiviral nucleosidkombination
ES2113881T3 (es) Derivados y analogos de acido 2-desoxi-2,3-didehidro-n-acetil neuraminico y su utilizacion como agentes antivirales.
ES435273A1 (es) Un procedimiento de preparacion de n-(1-bencil-pirrolidi- nil-2-alcohil) -benzamidas sustituidas.
ES2083597T3 (es) Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
DK297976A (da) Rullepumpehoved til skiftende pumpning navnlig egnet til cirkulation af blod uden for legemet
SE7701441L (sv) Nytt piperazinyluracilsalt
ES2038969T3 (es) Procedimiento para la renaturalizacion de proteinas.
FI860018A0 (fi) Laekemedelspreparat med reducerad toxisitet.
DK178188D0 (da) Antivirusmiddel
SE7700626L (sv) Patientstol for ltandbehandling
DK0500953T3 (da) Potentiator af antineoplastisk virkning og antineoplastisk middel
NO902157D0 (no) Butensyrederivater for terapeutisk anvendelse.
FR2362852A1 (fr) Derives de la phenothiazine, leur preparation et leurs utilisations therapeutiques
ES460621A1 (es) Procedimiento de sintesis de n-(1'-alil-2'-pirrolidilmetil)-2,3-dimetoxi-5-sulfamoilbenzamida.
DE3586457D1 (de) Solubilisierungsverfahren im moment der anwendung eines aktiven lipophilen prinzipes in waessriger loesung zum zweck der intravenoesen verabreichung.
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
ES2054097T3 (es) Agente para el tratamiento de enfermedades inflamatorias cronicas del intestino.
IT1114869B (it) Derivati attivi di metilammina,composizioni terapeutiche che li contengono e procedimenti per preparare i detti derivati e le dette composizioni
ES2135384T3 (es) Derivados de 1,4-dihidropiridina opticamente activos y procedimientos para producirlos.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7701441-3